wedbush calendar upcom event
sell indian food deliveri busi zomato rip band-aid
report media last week last night offici sold food deliveri busi india
zomato well establish local competitor exchang indian start-up cash reimburs
zomato good servic tax given zomato recent valuat billion privat market would valu
sale roughli million end dark chapter eat india struggl gain share vs entrench
domest competitor zomato swiggi togeth control roughli food deliveri market india take
step back smart strateg move cut loss food deliveri busi india compani strateg
financi vision hit profit believ move commonplac dara co
ration compani eat food deliveri busi take rate profit prospect pressur
food deliveri busi domest intern need narrow vision food deliveri side
hous opinion investor frustrat around busi segment continu grow across street mani
market need decid financi strateg make sens aggress go ultim cede share
look altern perfect exampl middl east market struggl decid acquir
careem transact believ one smartest move last year gain share
fertil ride share market opportun take step back believ investor optim start final perk
dark period sinc ipo last year heel improv profit prospect growth ride share
front ration pricing/incent structur domest also benefit credibl
built piec piec view sale indian food deliveri busi smart help improv bottom-
line structur eat move heavi lift ahead dara team regain street credibl
guidanc come week potenti posit inflect point stock maintain outperform rate
price target
put profit ahead balanc sheet growth
despit cut flatten yield curv rf gener posit oper leverag commit
deliv believ even assum declin net interest incom fee incom growth
strong grow fee incom mid-singl digit achiev given strong momentum
rf still earli stage reap benefit simplifi grow initi expect lead flat
expens growth still invest compani rf view expens growth function revenu growth
revenu growth come expect rf will delay certain invest pull forward cost
save ensur deliv posit oper leverag also rf better posit next credit downturn given
de-risk taken place last year
wedbush secur seek busi compani cover
research report thu investor awar firm may
conflict interest could affect object report investor
consid report singl factor make invest decis
pleas see page report analyst certif import
slight adjust ep estim believ revenu
growth come weaker expect rf flexibl willing adjust expens growth accordingli ensur
gener posit oper leverag
deliv solid result invest futur
despit one best perform region bank stock outperform region bank index
kre still trade one lower price-to-earnings group discount despit consist beat consensu
report strongest organ growth among peer benefit bolt-on fee incom acquisit
remain commit deliv posit oper leverag improv profit despit fight
rate cut flatter yield curv reiter medium rotc target vs steeper
yield curv continu solid econom growth need sole reli macro environ get
transform top program new strateg revenu initi discuss detail
report posit much stronger oper leverag help drive higher rotc
rais ep estim respect reflect slightli
stronger averag loan growth origin forecast driven solid consum loan growth
multipl catalyst share
wedbush view posit share highlight sever import value-driv clinic catalyst across
compani four clinical-stag product candid rare autoimmun autoinflammatori diseas
includ top-line ph rhapsodi rilonacept recurr pericard anticip ph readout
diseas character chronic pruritu top-line ph readout mavrililumab giant cell arter gca
initi ph healthi volunt data report commentari
marg march market
wedbush view transform commerci compani decemb submit bla fda
lead asset margetuximab fc-engin monoclon antibodi intend metastat breast cancer
patient second interim analysi ph sophia studi sabc meet continu show progress
free surviv benefit month marg chemo arm vs month trastuzumab chemo arm intent-
to-treat popul key us approv see note howev without statist signific overal surviv benefit
eu market remain close oncolog drug advisori committe odac meet like part fda review
marg expect approv also investig marg ph mahogani trial advanc gastric
gastroesophag junction cancer patient combin therapi initi safeti efficaci data
first modul studi chemo-fre regimen expect path potenti acceler approv
modul base object respons rate single-arm studi also develop dart bispecif
flotetuzumab r/r aml on-going discuss fda aim defin registr path go forward
program initi data flotetuzumab combin mab slate mgnx
on-going ph studi dart nine tumor type solid liquid dose escal data
may june chicago il provid guidanc tumor indic pursu ph develop compani
mab enoblituzumab investig fully-enrol ph studi agent squamou cell
carcinoma head neck sschn non-smal cell lung cancer nsclc patient compani expect begin
chemo-fre studi recurr metastat sschn combo soon begin ph
studi earli aim complet dose escal studi
dart continu dose expans addit guidanc develop program expect
compani decid discontinu dart dart program part strateg priorit
pipelin
footwear apparel
increment insight europ pitti uomo
attend pitti uomo trade show florenc itali focus primarili fashion footwear apparel europ
addit channel check citi report present takeaway meet discuss held www
sauconi brand presid ann cavassa addit repres www sperri cal allen edmond deck hoka
one one
pleas see full report detail analysi
preview valu midst unfavor weather guidanc uncertainti
share under-perform bp sinc compani last earn report investor increasingli
expect soft result soft guidanc compani next report januari bmo concur
unfavor weather tough comparison like drove soft transitori weak price
share bigger question go-forward plan new ceo lawton join compani week ago
lawton bring omnichannel merchandis leadership experi need drive continu growth see
strong choic new ceo like take time formul plan action end expect compani
guid normal possibl leav room increment invest mr lawton see fit product initi
build ok sale outlook like mean guidanc flattish oper margin ep bracket consensu
believ price share importantli tsco capabl nearli par rest retail
financi strong put posit strength drive disrupt farm ranch retail categori
like requir major departur compani guidanc said invest question
mr lawton consid benefit build industry-lead omnichannel capabl other
build would like get credit investor plan clear payoff nonetheless see explicit new
invest cycl guidanc unlik given mr lawton short time job trade
histor five-year averag ntm price-to-earnings averag rel see valu midst transient
weather pressur uncertainti maintain outperform rate
strong healthcar cloud check strateg vision start
base recent check field increment posit head believ
compani done commend job execut strateg initi field continu laser focus
build global cloud healthcar ai driven busi grow sustain revenue/earn stream
upcom decemb quarter believ anoth beat rais special horizon cloud healthcar
pipelin deal flow convers appear stronger expect improv execut strateg vision start
take hold
opinion linchpin stori compani aggress goe dragon medic cloud
healthcar opportun still earli inning play remain core part bull thesi
name head
believ underli visibl increas model key healthcar initi along healthi
profitability/cash flow ultim lay groundwork strateg organ growth re-acceler stori head
beyond result re-rat stock street recogn new improv nuanc stori
go forward believ number potenti move higher re-rat stock take place share
set well next month stori play street start appreci new
sum increment bullish given posit check field specif around cloud
healthcar opportun pois see discern secular tailwind beyond thu rais
price target reflect dynam reiter outperform rate
takeaway asia phase deal risk trade
opportun travel throughout asia past week meet investor privat tech compani
day trip major topic convers throughout meet phase us/china deal ink last
week within china surround countri visit key focu latest truce mean
tech suppli chain cloud gener competit environ countri especi head
transform cycl lot noise/detail need work trade talk gener
view ground dark cloud lift near-term risk trade among investor around
us chines tech compani come year play key trend mani global focus investor
sat cautiou environ given headlin risk trade battl
increment bullish look aggress faang name semi stock softwar name particular
alibaba baidu tencent remain core chines tech name focu recur theme around shift
cloud among chines compani alibaba firmli posit leader attack estim
billion next five year
major focu term play cloud stori us focu name opinion believ
market share shift valuat re-rat stori redmond reson investor given nadella abil gain
share vs like aw jedi front center super cycl thesi front center mani investor
look play transform technolog build come year us china view
two separ path us china ecosystem carrier smartphon maker infrastructur
build out/compon lead massiv invest dollar global combin cours
current trade climat limit cross pollin us china huawei situat remain major x-
variabl aggress stock side aisl cycl clear view
remain best way play theme amount spend china around infrastructur build
eye pop along ai innov key theme cours term given bullish
supplier check week region confid cupertino abil hit million iphon unit
million unit realist possibl super cycl ahead believ giga
shanghai hit stride demand model build key region china demand thesi add anoth
per share stori chines investor realli focus market share impact domest ev player
next month believ could dramat fremont flex muscl china could add
anoth unit deliveri overal stori enabl hit key annual threshold walk away
investor meet sens increas bullish among investor throughout asia tech stock trade
tension settl green light aggress tech stock faang name lead way
inflect point servic hclt result neg
maintain neutral rate post-weak result cautiou commentari tier off-shore peer wipro hcl
result like continu impact structural-challeng financi servic capit market invest bank
retail amazon effect vertic case account sector revenu view result
bode neg report result februari top servic pick outperform
rate glob wn
wedbush-host nyc breakfast infi cfo novemb
pleas contact wedbush sale detail
last week hardwar news abound ex volcan erupt
enter anoth earn season attempt avoid comment directli earn rather focu
deriv implic newsflow
tsmc tsmc number guidanc expectedli strong see interest point tsmc high
expect util impli strength semiconductor build contrast typic season
memori price dram nand continu inflect higher around chines new year typic
weakest point year demand see result posit indic health tech/semiconductor
also given robust condit hard time project next downtick particularli nand
demand see signific boost game start
 arguabl lone spot concern cut price xeon support higher densiti memori
digitim theoriz pc cpu shortag could last would surpris case idc
project downtick pc shipment year win upgrad cycl slow
philippin volcano primari technolog suppli chain concern tie potenti disrupt taal volcano appear
center around mlcc encount question regard potenti hdd implic verifi
issu front ten thousand philippin current displac hope volcan activ continu
diminish limit damag suffer filipino peopl live proxim volcano
commerc strategi get highlight nrf confer
attend nrf vision confer nyc last week offer takeaway pinterest social commerc
pinterest present multipl time confer includ ceo silbermann head retail strategi ami vener
head cpg strategi arthur sevilla also share takeaway facebook instagram approach social
commerc social media compani continu increasingli focu commerc link content discoveri
transact narrow highlight trend view pin initi report june view pinterest
visual discoveri strength well user top funnel discoveri high intent usag platform well-posit
captur grow trend
biggest singl take-away point confer accord ceo silbermann work backward inspir
top funnel transact bottom-funnel platform huge white space pinterest go intent
focus pinterest core compet inspir pinterest year roadmap ahead facilit hand
consum retail
pleas see full note detail
compani cover respect research analyst analyst certifi view express research report
accur reflect research analyst person view subject secur compani part
compens directli indirectli relat specif recommend view contain research report
outperform expect total return stock outperform rel median total return analyst analyst
team coverag univers next month
neutral expect total return stock perform in-lin median total return analyst analyst team
coverag univers next month
under-perform expect total return stock under-perform rel median total return analyst
analyst team coverag univers next month
invest rate base expect perform stock base anticip total return price target rel
stock analyst coverag univers analyst team coverag
januari
januari
distribut rate requir finra rule howev ws stock rate outperform neutral under-perform
close conform buy hold sell respect pleas note howev definit ws stock rate
rel basi
analyst respons prepar research report receiv compens base specif invest bank activ
analyst receiv compens base upon variou factor includ ws total revenu portion gener
ws invest bank activ
